Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 950-627-7 | CAS number: 1042950-30-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- (ATC method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Body weight
(at start of 1st administration) 213.4 – 307.7 g
Age (at start of administration) Approx. 9 – 10 weeks
Identification of animals By coloured marks and cage label
Duration of experiment
At least 5 adaptation days
1 test day
2 recovery weeks
Diet
Commercial diet, ssniff® R/M-H V1534 (ssniff Spezialdiäten GmbH, 59494 Soest, Germany; see Appendix 3: Composition of the diet) served as food. Tap water was available ad libitum.
Periodic analysis of the food for contaminants based on EPA/USA is conducted by LUFA-ITL (see Appendix 3: Limitation for contaminants in the diet). Certificates of analysis of the composition and for contaminants were provided by the manufacturer and are QAU archived.
Housing
Granulated textured wood (Granulat A2, J. Brandenburg, 49424 Goldenstedt, Germany) was used as bedding material for the cages. The cages were changed and cleaned twice a week.
Periodic analysis of the bedding material for contaminants based on EPA/USA is conducted by LUFA-ITL (see Appendix 3: Limitation for contaminants in the bedding material).
During the 14-day observation period the animals were singly in MAKROLON cages (type III plus) at a room temperature of 22 °C ± 3 °C (maximum range) and a relative humidity of 55 % ± 10 % (maximum range). Deviations from the maximum range caused for example during cleaning procedures are dealt with in SOPs.
The rooms were lit (about 150 lux at approx. 1.50 m room height) and darkened for periods of 12 hours each.
Drinking water
Drinking water in bottles was offered ad libitum.
Drinking water is examined according to the 'Deutsche Trinkwasserverordnung 2001' [German Regulations on drinking water 2001] by the Hamburger Wasserwerke, 20539 Hamburg, Germany, at least four times a year.
In addition, drinking water samples taken at LPT are analysed by LUFA-ITL once a year for means of bacteriological investigations according to the 'Deutsche Trinkwasserverordnung 2001.
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Selection of route of administration
According to the OECD/EC guidelines
Vehicle
The test item was diluted to concentrations of 2000 and 300 mg/kg b.w. using tap water
Administration volume
10 mL/kg b.w. per application
Dose levels
2000 and 300 mg/kg b.w. - Doses:
- Dose levels
2000 and 300 mg/kg b.w. - No. of animals per sex per dose:
- Number of animals
Limit Test
3 animal at the dose level of 2000 mg/kg b.w.
First and second step
6 animals at the dose level of 300 mg/kg b.w. - Control animals:
- no
- Details on study design:
- Principle of the ATC-test method
This procedure permits the identification of the 'acute-toxic-class' (ATC), a measurement of the acute toxicity by the oral route.
The test item is administered orally by gavage at a single dose level to a group of experimental animals. The dose used is selected from a series of defined dose levels. Due to the small number of animals used with this method, there is no need to perform a range finding test.
The test item is tested using a stepwise procedure, each step or dose level uses three female animals. The results of each step determine if:
o no further testing is needed,
o the next step will be performed with the same dose,
o the next step will be performed at the next higher or next lower dose level.
Starting at 2000 mg/kg b.w.
o Testing at 2000 mg/kg b.w.:
Three animals of one sex (preferably females) are treated at 2000 mg/kg b.w. (first step).
If two to three animals die, testing at 300 mg/kg b.w. should be performed.
If no to one animal dies, the test item should be retested (second step) with 2000 mg/kg b.w., using three animals of the same sex.
If, in this second step, two to three animals die, testing at 300 mg/kg b.w. should be performed. If, in this second step, no to one animal dies, no further testing is necessary.
o Testing at 300 mg/kg b.w.:
If the results of the test at 2000 mg/kg b.w. indicate the need for further testing at a lower dose level.
Three female animals are treated at 300 mg/kg b.w. (first step).
If two or three animals die, testing at 50 mg/kg b.w. should be performed.
If fewer than two animals die, the test item should be retested (second step) with 300 mg/kg b.w., using three animals of the same sex.
If, in this second step, two or three animals die, testing at 50 mg/kg b.w. should be performed. If, in this second step, no to one animal dies, no further testing is necessary.
o Testing at 50 mg/kg b.w.:
If the results of the test at 300 mg/kg b.w. indicate the need for further testing at a lower dose level.
Three female animals treated at 50 mg/kg b.w. (first step).
If two or three animals die, testing at 5 mg/kg b.w. should be performed.
If fewer than two animals die, the test item should be retested (second step) with 50 mg/kg b.w., using three animals of the same sex.
If, in this second step, two or three animals die, testing at 5 mg/kg b.w. should be performed. If, in this second step, no to one animal dies, no further testing is necessary. - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- >= 300 - <= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Under the present test conditions, two administrations at an interval of 1 hour of 2000 mg of the test item/kg b.w. revealed slightly to moderately reduced motility, slight to moderate ataxia, slightly reduced muscle tone, slight dyspnoea and slight ptosis in three animals employed. All three animals died prematurely (2/3 animals) or were humanely killed (1/3 animals) after gavage of the second dose (within 3 hours after start of the experiment).
Two administrations at an interval of 1 hour of 300 mg the test item b.w. revealed slightly reduced motility, slight ataxia and slight dyspnoea in six animals employed (first and second step). One animal died prematurely after gavage of the second dose (within 3 hours after starting the experiment). - Clinical signs:
- other: Under the present test conditions, two administrations at an interval of 1 hour of 2000 mg of the test item/kg b.w. revealed slightly to moderately reduced motility, slight to moderate ataxia, slightly reduced muscle tone, slight dyspnoea and slight ptosi
- Gross pathology:
- No pathological changes were observed at necropsy.
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Under the present test conditions, two administrations at an interval of 1 hour of 2000 mg PU-2019-872/kg b.w. revealed slightly to moderately reduced motility, slight to moderate ataxia, slightly reduced muscle tone, slight dyspnoea and slight ptosis in three animals employed. All three animals died prematurely or were humanely killed after gavage of the second dose (within 3 hours after starting the experiment).
Two administrations at an interval of 1 hour of 300 mg PU-2019-872/kg b.w. revealed slightly reduced motility, slight ataxia and slight dyspnoea in six animals employed (first and second step). One animal died prematurely after gavage of the second dose (within 3 hours after starting the experiment).
All surviving animals gained the expected body weight.
According to the Globally Harmonized Classification System (GHS) the test item requires labelling of category 4 for acute oral toxicity (as LD50 is between 300 - 2000 mg/kg b.w.). - Executive summary:
Under the present test conditions, two administrations at an interval of 1 hour of 2000 mg PU-2019-872/kg b.w. revealed slightly to moderately reduced motility, slight to moderate ataxia, slightly reduced muscle tone, slight dyspnoea and slight ptosis in three animals employed. All three animals died prematurely or were humanely killed after gavage of the second dose (within 3 hours after starting the experiment).
Two administrations at an interval of 1 hour of 300 mg PU-2019-872/kg b.w. revealed slightly reduced motility, slight ataxia and slight dyspnoea in six animals employed (first and second step). One animal died prematurely after gavage of the second dose (within 3 hours after starting the experiment).
All surviving animals gained the expected body weight.
According to the Globally Harmonized Classification System (GHS) the test item requires labelling of category 4 for acute oral toxicity (as LD50 is between 300 - 2000 mg/kg b.w.).
Reference
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 300 mg/kg bw
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.